Anthera Pharmaceuticals, Inc. Seeks IPO for Company With No Sales as Offerings Slump
Bloomberg -- Anthera Pharmaceuticals Inc. plans to raise as much as $69 million in an initial public offering this week, testing whether shareholders can double the value of their investment in a company without sales or profits.